COMPANY REGISTRATION NUMBER:
08155462
|
Filleted Unaudited Financial Statements |
|
|
Statement of Financial Position |
|
31 December 2025
Fixed assets
Current assets
|
Cash at bank and in hand |
530,687 |
530,687 |
|
|
|
|
Creditors: amounts falling due within one year |
5 |
1,814,331 |
1,814,331 |
|
------------ |
------------ |
|
Net current liabilities |
1,283,644 |
1,283,644 |
|
------------ |
------------ |
|
Total assets less current liabilities |
(
1,283,643) |
(
1,283,643) |
|
------------ |
------------ |
|
Net liabilities |
(
1,283,643) |
(
1,283,643) |
|
------------ |
------------ |
|
|
|
|
Capital and reserves
|
Called up share capital |
100 |
100 |
|
Profit and loss account |
(
1,283,743) |
(
1,283,743) |
|
------------ |
------------ |
|
Shareholder deficit |
(
1,283,643) |
(
1,283,643) |
|
------------ |
------------ |
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
-
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
|
Statement of Financial Position (continued) |
|
31 December 2025
These financial statements were approved by the
board of directors
and authorised for issue on
10 September 2026
, and are signed on behalf of the board by:
Company registration number:
08155462
|
Notes to the Financial Statements |
|
Year ended 31 December 2025
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1 Apsley Way, London, NW2 7HF, United Kingdom.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on the going concern basis, not withstanding the net liabilities of £1,283,643 on the basis that Vitabitoics Limited, the company's immediate parent company has provided the company with an undertaking that it will not seek repayment of its dues for the foreseeable future.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholder deficit during the current year or prior year.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Investments
|
Shares in group undertakings |
|
£ |
|
Cost |
|
|
At 1 January 2025 and 31 December 2025 |
1 |
|
---- |
|
Impairment |
|
|
At 1 January 2025 and 31 December 2025 |
– |
|
---- |
|
|
|
Carrying amount |
|
|
At 31 December 2025 |
1 |
|
---- |
|
At 31 December 2024 |
1 |
|
---- |
|
|
5.
Creditors:
amounts falling due within one year
|
2025 |
2024 |
|
£ |
£ |
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
1,813,012 |
1,813,012 |
|
Other creditors |
1,319 |
1,319 |
|
------------ |
------------ |
|
1,814,331 |
1,814,331 |
|
------------ |
------------ |
|
|
|
6.
Events after the end of the reporting period
1) The entire share capital of
Avensys Investments Ltd
was transferred to Cyan Group Property Holding Company Limited, a company incorporated in Jersey, at a value equivalent to the carrying value recognised in these accounts as at 30th June 2026. 2) Amounts due to Vitabiotics Limited by Avensys Investments Ltd
were partially waived on 30th June 2026.
7.
Related party transactions
The company has taken advantage of the exemption granted by paragraph 33.1(a) of FRS102, Related Party Disclosures, not to disclose transactions with group companies which are wholly owned subsidiaries of the group.
8.
Controlling party
The immediate parent undertaking and the smallest and largest group to consolidate these financial statements is Vitabiotics Limited, a company registered in England and Wales. Copies of the Vitabiotics Limited consolidated financial statements are publically available at Companies House. The directors consider the ultimate controlling parent undertaking to be Vitabiotics Group Holdings Limited, a company incorporated in the British Virgin Islands.